Tetralogy of Fallot with absent pulmonary valve syndrome: A 34-year African single centre experience TETRALOGY 
OF FALLOT
A common finding in these patients is 22q11.2 deletion, with a frequency of approximately 44%. (9) The presence of the 22q11.2 deletion is important to exclude because of the association with immunodeficiency, a worse prognosis and reduced survival. (10) The survival rates after surgical intervention have improved over time. In a recent Australian study, the overall operative mortality was 13.5% over a 38-year period. However, they
showed no operative mortality in 15 consecutive patients (4, 5) In the current era, patients with this condition can be confidently diagnosed in utero with foetal echocardiography. (6) However, foetal echocardiography is not readily available in public hospitals in resource constrained countries, making prenatal diagnosis uncommon. Approximately 40% -50% of these patients present as infants with respiratory symptoms ranging from stridor to severe respiratory compromise, requiring mechanical ventilation. years of the study to a combination of increased surgical experience, the application of extensive branch pulmonary artery reduction techniques and a trend towards increased utilisation of valved conduits. The overall survival in this study was 81.4% ± 5.6% at 10 years. (8) There is currently no literature emanating from Africa that has been published on TOF with APVS. The aim of the study was to review the characteristics and outcomes of patients presenting with this condition at a tertiary African referral hospital. 
METHODS

RESULTS
A total of 15 patients with TOF and APVS were seen over the 34-year study period (Table 1) . APVS compromised 3%
(15/514) of all TOF patients.
Of the 15 patients, over two-thirds (67%) were male. Ten (67%) patients presented before 1 year of age. The majority of patients (67%) had respiratory symptoms as their cause of presentation, of whom 6 (40%) were infants.
Fourteen (93%) patients were described to have the characteristic systolic and diastolic (to-and-fro) cardiac murmur on clinical examination at presentation. Only 5 (33%) patients underwent surgical intervention ( Table 1 ).
The majority were done between 1981 and 1998, and in children older than a year of age. Review of follow-up data showed that 7 (47%) patients were known to be alive at 1 year of age while 4 (27 %) were known to be alive at 10 years of age. One patient died during the neonatal period. The follow up of patients improved over the last 3 years of the study period. Three out of the 4 patients that have presented since 2014, continue to be followed up at the cardiac clinic. of all TOF patients. (1, 2) Ten (67%) patients presented before 1 year of age in our study. Typically, patients with TOF and APVS are divided into 2 categories: those who present early with respiratory symptoms (infant-type APVS) and those who present later (childhood-type). (5, 13) The majority of the study patients (67%) had respiratory symptoms as their cause of presentation, of which 6 (40%) were infants. A to-and-fro murmur (ejection systolic and early diastolic murmur) at the left sternal border is a characteristic clinical sign in TOF and APVS. (7, 13) The majority of our patients (93%) had a to-andfro murmur on clinical examination which was diagnostic at presentation. Given the limited availability of prenatal ultrasound in a resource poor setting like ours, TOF and APVS should be suspected in a child less than 1 year presenting with respiratory symptoms and a characteristic to-and-fro murmur.
As 22q11.2 deletion is a common finding in patients with TOF and APVS, routine screening for this deletion should be which has an impact on management and outcome. (9, 10) TOF with APVS may occasionally be associated with defects such as atrial septal defects and absent left pulmonary artery. Follow-up data of the study patients is poor, with only 4 (27%) of the 15 patients known to be alive at 10 years of age. One patient died in the neonatal period. Seven (47%) patients were alive at 1 year of age. The potential for good outcomes was documented in a study by Yong et al. in Australia over a 38-year period, which showed that the overall survival at 10 years was 81.4% ± 5.6%. (8) In conclusion, TOF with APVS is a rare condition compromising 3% of all TOF patients presenting to an African tertiary care centre, which correlates with the mainstream literature. The 22q11.2 deletion syndrome was suspected in 33% of patients but confirmed in a small number (13%), largely due to several of our patients presenting prior to the availability of routine testing. APVS should be suspected in a child less than 1 year presenting with respiratory symptoms and a characteristic toand-fro murmur. A good outcome can be expected if diagnosed early and the appropriate surgical management provided.
The limitations of the study were that the data was analysed retrospectively at a single institution which has historically experienced numerous resource constraints, and where follow up of patients has been poor. As such, any inferences drawn from these data were limited.
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